Vor Biopharma Inc [VOR] stock prices are up 5.11% to $1.85 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VOR shares have gain 4.52% over the last week, with a monthly amount drifted -11.48%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Vor Biopharma Inc [NASDAQ: VOR] stock has seen the most recent analyst activity on July 26, 2022, when Wedbush initiated its Outperform rating and assigned the stock a price target of $18. Previously, Goldman started tracking the stock with Neutral rating on April 27, 2022, and set its price target to $6. On December 17, 2021, H.C. Wainwright initiated with a Buy rating and assigned a price target of $26 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $38 on December 03, 2021. Oppenheimer initiated its recommendation with a Outperform and recommended $30 as its price target on December 02, 2021. JMP Securities started tracking with a Mkt Outperform rating for this stock on October 19, 2021, and assigned it a price target of $40. In a note dated March 25, 2021, B. Riley Securities initiated an Buy rating and provided a target price of $60 on this stock.
The stock price of Vor Biopharma Inc [VOR] has been fluctuating between $1.62 and $5.70 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Vor Biopharma Inc [NASDAQ: VOR] shares were valued at $1.85 at the most recent close of the market. An investor can expect a potential return of 224.32% based on the average VOR price forecast.
Analyzing the VOR fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.61 and Total Capital is -0.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.7367 points at the first support level, and at 1.6233 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.9067, and for the 2nd resistance point, it is at 1.9633.
Vor Biopharma Inc [VOR] reported earnings per share of -$0.39 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.5/share, meaning a difference of $0.11 and a surprise factor of 22.00%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$0.49 per share as compared to estimates of -$0.47 per share, a difference of -$0.02 representing a surprise of -4.30%.
Ratios To Look Out For
It’s worth pointing out that Vor Biopharma Inc [NASDAQ:VOR]’s Current Ratio is 9.04. As well, the Quick Ratio is 9.04, while the Cash Ratio is 2.01.
